Response to Letter to the Editor From Malozowski: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”.

MLA

Thornton, Paul S., et al. “Response to Letter to the Editor From Malozowski: ‘Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 HeiGHt Trial.’” Journal of Clinical Endocrinology & Metabolism, vol. 107, no. 5, May 2022, pp. e2215–16. EBSCOhost, https://doi.org/10.1210/clinem/dgab879.

APA

Thornton, P. S., Maniatis, A. K., Aghajanova, E., Chertok, E., Zhengning Lin, Wenjie Song, Christoffersen, E. D., Breinholt, V. M., Giorgadze, E., Korpal-Szczyrska, M., Hofman, P. L., Karpf, D. B., Shu, A. D., & Beckert, M. (2022). Response to Letter to the Editor From Malozowski: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.” Journal of Clinical Endocrinology & Metabolism, 107(5), e2215–e2216. https://doi.org/10.1210/clinem/dgab879

Chicago

Thornton, Paul S., Aristides K. Maniatis, Elena Aghajanova, Elena Chertok, Zhengning Lin, Wenjie Song, Eva Dam Christoffersen, et al. 2022. “Response to Letter to the Editor From Malozowski: ‘Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 HeiGHt Trial.’” Journal of Clinical Endocrinology & Metabolism 107 (5): e2215–16. doi:10.1210/clinem/dgab879.